Back to Index
Wafaa A. Elatre, MD, PhD
Assistant Professor of Clinical Pathology
HC4 1450 San Pablo Street Health Sciences Campus Los Angeles
+1 323 442 9714


Stern HM, Gardner H, Burzykowski T, Elatre W, O'Brien C, Lackner MR, Pestano GA, Santiago A, Villalobos I, Eiermann W, Pienkowski T, Martin M, Robert N, Crown J, Nuciforo P, Bee V, Mackey J, Slamon DJ, Press MF. PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance. Clin Cancer Res. 2015 May 1; 21(9):2065-74. View in: PubMed

Gordon MA, Gundacker HM, Benedetti J, Macdonald JS, Baranda JC, Levin WJ, Blanke CD, Elatre W, Weng P, Zhou JY, Lenz HJ, Press MF. Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial. Ann Oncol. 2013 Jul; 24(7):1754-61. View in: PubMed

Desai B, Elatre W, Quinn DI, Jadvar H. FDG PET/CT demonstration of pancreatic metastasis from prostate cancer. Clin Nucl Med. 2011 Oct; 36(10):961-2. View in: PubMed

Heywood JT, Elatre W, Pai RG, Fabbri S, Huiskes B. Simple clinical criteria to determine the prognosis of heart failure. J Cardiovasc Pharmacol Ther. 2005 Sep; 10(3):173-80. View in: PubMed

Chang R, Elatre WA, Heywood JT. Effect of nesiritide on length of hospital stay in patients with decompensated heart failure. J Cardiovasc Pharmacol Ther. 2004 Sep; 9(3):173-7. View in: PubMed

Powered bySC CTSI